A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers ...
Alyssa Tapley, 16, became the first patient with an aggressive form of leukaemia to have the experimental treatment in 2022.
CDT1 overexpression suppresses DNA replication and triggers DNA damage linked to cancer, finds study
A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...
Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology
Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...
The genetically engineered food is also protein packed and sustainable, say scientists. Chinese researchers used gene-editing ...
Detectives often find important clues by digging through rubbish. That approach paid off tremendously for systems biologist ...
Scientists from Duke-NUS Medical School and their international collaborators have developed a new computational tool that ...
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...
Data presented at ASH suggested that CDK4/6 inhibitors given with chemo for Rb-deficient tumors could mitigate the risk of secondary myeloid neoplasms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results